TH-MYCN tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapy

K. O. McNerney, S. Karageorgos, G. M. Ferry, A. J. Wolpaw, C. Burudpakdee, P. Khurana, C. N. Toland, R. Vemu, A. Vu, M. D. Hogarty*, H. Bassiri

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'TH-MYCN tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapy'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Immunology and Microbiology

Neuroscience